Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong PKU High Tech Huatai Pharmaceutical is a comprehensive pharmaceutical company located in Weifang, Shandong Province, China. As a subsidiary of PKU High-Tech, it leverages a strong academic and industrial background to develop and manufacture a variety of chemical drugs. The company's product portfolio is primarily focused on essential therapeutic areas, including cardiovascular diseases, anti-infectives, and gastrointestinal health. Its manufacturing facilities are GMP-certified, enabling the production of multiple dosage forms such as tablets, capsules, and small-volume injections. Shandong PKU High Tech Huatai Pharmaceutical is committed to providing high-quality generic medications for both the domestic Chinese market and international distribution. The company integrates R&D, production, and marketing to maintain its position in the competitive pharmaceutical landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong PKU High Tech Huatai Pharmaceutical.